Halozyme Therapeutics Overview
Halozyme Therapeutics Target Price
Analysts' 12-month price predictions for HALO.
Share Price
$73.4
Average Target Price
$62.00
15.5% downside
15.5% downside1 analysts in the last 4 months
High: $62 | Low: $62
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-14 | Morgan StanleySean Laaman | $62 | 15.5% downside |  |
| 2024-11-15 | Piper SandlerJoseph Catanzaro | $52 | 29.2% downside | |
| 2024-06-07 | H.C. WainwrightMitchell Kapoor | $65 | 11.4% downside | |
| 2024-06-07 | Piper SandlerJoseph Catanzaro | $51 | 30.5% downside | |
| 2024-06-07 | Wells FargoMohit Bansal | $58 | 21% downside | |
| 2024-06-06 | Goldman SachsCorinne Jenkins | $44 | 40.1% downside | |
| 2023-01-11 | Leerink Partners | $61 | 16.9% downside | |
| 2022-12-21 | Morgan Stanley | $65 | 11.4% downside | |
| 2022-11-28 | Wells Fargo | $65 | 11.4% downside | |
| 2022-11-22 | J.P. Morgan | $54 | 26.4% downside | |